Comprehensive and Individualized Patient Care in Idiopathic Pulmonary Fibrosis:
Refining Approaches to Diagnosis, Prognosis, and Treatment
Implement multidisciplinary clinical and imaging approaches to achieve more timely and accurate diagnosis of IPF
Develop IPF treatment strategies based on key guideline recommendations and examine the supporting clinical trial data
Describe key elements of an individualized approach to IPF treatment that involves shared decision-making
Standard immunosuppressive therapy is no longer indicated, whereas pirfenidone, nintedanib, and antacid therapy are all conditionally recommended for use. Individualizing treatment is important in light of potential improved adherence to both drug therapy and health behaviors. An early referral to an interstitial lung disease center offers the advantages of comprehensive diagnostic and disease-management expertise, potential enrollment in a clinical trial, and evaluation for transplantation.